• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

Comprehensive Overview of Ethyl 6-Bromoisoquinoline-1-carboxylate (CAS No. 1020576-70-8)

Ethyl 6-Bromoisoquinoline-1-carboxylate (CAS No. 1020576-70-8) is a specialized organic compound widely utilized in pharmaceutical research, material science, and fine chemical synthesis. This brominated isoquinoline derivative has garnered significant attention due to its versatile applications in drug discovery and as a key intermediate in the synthesis of complex heterocyclic compounds. Researchers and industries are increasingly exploring its potential in developing novel therapeutic agents, particularly in oncology and neurology.

The molecular structure of Ethyl 6-Bromoisoquinoline-1-carboxylate features a bromine atom at the 6-position and an ethyl carboxylate group at the 1-position of the isoquinoline scaffold. This unique arrangement enhances its reactivity, making it a valuable building block for cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings. These reactions are pivotal in constructing biologically active molecules, aligning with the growing demand for high-value intermediates in medicinal chemistry.

In recent years, the compound has been linked to advancements in targeted drug delivery systems and small-molecule inhibitors. With the rise of personalized medicine, researchers are investigating its role in modulating specific protein-protein interactions, a hot topic in cancer therapy and neurodegenerative disease research. Its compatibility with modern green chemistry principles, such as solvent-free reactions and catalytic recycling, further boosts its appeal in sustainable pharmaceutical manufacturing.

From a commercial perspective, Ethyl 6-Bromoisoquinoline-1-carboxylate is available in high purity grades (≥98%) to meet the stringent requirements of GMP-compliant production. Its stability under ambient conditions and compatibility with automated synthesis platforms make it a preferred choice for high-throughput screening (HTS) workflows. These attributes address the industry's need for scalable and cost-effective intermediates.

Analytical techniques like HPLC, NMR, and mass spectrometry are routinely employed to validate the compound's identity and purity. Such rigorous quality control ensures reproducibility in research, a critical factor for academic and industrial labs focusing on structure-activity relationship (SAR) studies. Additionally, its spectral data is well-documented in public databases like PubChem and Reaxys, facilitating seamless integration into digital chemistry tools.

Emerging trends in AI-driven drug design have further amplified interest in Ethyl 6-Bromoisoquinoline-1-carboxylate. Computational models frequently utilize its structural motifs to predict novel bioactive compounds, aligning with the broader shift toward in silico experimentation. This synergy between synthetic chemistry and machine learning underscores its relevance in next-generation drug development pipelines.

In summary, Ethyl 6-Bromoisoquinoline-1-carboxylate (CAS No. 1020576-70-8) represents a critical tool for modern chemical research. Its multifaceted applications—from medicinal chemistry to sustainable synthesis—position it at the forefront of innovation. As scientific inquiries into heterocyclic compounds and precision medicine expand, this compound is poised to remain a cornerstone of cutting-edge discoveries.

• 16732-70-0(Ethyl 5-bromo-1H-indole-2-carboxylate)
• 77199-09-8(Ethyl 5-bromopicolinate)
• 623583-88-0(Methyl 6-bromoquinoline-2-carboxylate)
• 882679-56-3(Ethyl 6-bromoisoquinoline-3-carboxylate)
• 62150-47-4(Ethyl 4-bromopicolinate)
• 103858-53-3(Ethyl 6-bromo-1H-indole-2-carboxylate)
• 476471-37-1(Ethyl 4-bromoquinoline-2-carboxylate)
• 50458-78-1(Isoquinoline-1-carboxylic Acid ethyl ester)
• 660830-62-6(Ethyl 7-bromoisoquinoline-3-carboxylate)
• 1020572-61-5(Ethyl 6-bromoquinoline-2-carboxylate)